Abstract
AbstractAnti‐muscle‐specific tyrosine kinase (MuSK) antibody‐positive myasthenia gravis (MG) patients sometimes present with bulbar symptoms such as tongue atrophy, nasal voice, dysarthria, or dysphagia and subsequent progressive weight loss. These symptoms may be confused with those of bulbar‐onset amyotrophic lateral sclerosis (ALS). We performed four videofluoroscopic evaluations and investigated the clinical course of a MuSK‐MG patient before and after administration of intensive immunotherapies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
